I am a
Home I AM A Search Login

Papers of the Week

2022 Nov 12

Pediatr Neurol


Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome.


Smegal LF, Vedmurthy P, Ryan M, Eagen M, Andrejow N W, Sweeney K, Reidy T G, Yeom SE, Lin DD, Suskauer SJ, Kalb LG, Salpekar JA, Zabel AT, Comi AM
Pediatr Neurol. 2022 Nov 12; 139:24-34.
PMID: 36508880.


A prior drug trial of cannabidiol for treatment-resistant epilepsy in patients with Sturge-Weber syndrome (SWS), a rare neurovascular condition, implicated improvements in neurological, quality of life (QOL), neuropsychologic, psychiatric, and motor outcomes.